The proportion of episodes delivered in residential settings increased with treatment intensity, with clients receiving intensive treatment more likely to receive treatment in this facility than in any other settings (Figure 6):
- non-recurring: around 1 in 7 episodes for alcohol (14%; 28,712 episodes) and amphetamines (15%; 18,666)
- recurring: around 1 in 5 episodes for alcohol (22%; 22,353 episodes) and amphetamines (18%; 16,994)
- intensive: around 1 in 3 episodes for alcohol (32%; 25,046 episodes) and amphetamines (31%; 14,535).
Episodes were more likely to end in unplanned completion where they were delivered in non-residential or residential treatment facilities, compared to outreach or home settings.
Figure 6: End reasons of episodes treating alcohol or amphetamines between 2013–14 and 2020–21, by treatment intensity cohort and delivery setting